Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Penny, Lovat"'
Autor:
Andrew Bryant, Fiona Pearson, Luke Vale, Dawn Craig, Diarmuid Coughlan, Catherine Richmond, Tafadzwa Patience Kunonga, Robert Ellis, Fiona R Beyer, R P W Kenny, Margaret Astin, Vasileios Kontogiannis, Claire H Eastaugh, Penny Lovat
Publikováno v:
BMJ Open, Vol 13, Iss 9 (2023)
Objectives To identify prognostic models for melanoma survival, recurrence and metastasis among American Joint Committee on Cancer stage I and II patients postsurgery; and evaluate model performance, including overall survival (OS) prediction.Design
Externí odkaz:
https://doaj.org/article/0e3c7e7f67dd46f6bc388388a402a56f
Autor:
Luke Vale, Patience Kunonga, Diarmuid Coughlan, Vasileios Kontogiannis, Margaret Astin, Fiona Beyer, Catherine Richmond, Dor Wilson, Dalvir Bajwa, Mehdi Javanbakht, Andrew Bryant, Wanwuri Akor, Dawn Craig, Penny Lovat, Marie Labus, Batoul Nasr, Timothy Cunliffe, Helena Hinde, Mohamed Shawgi, Daniel Saleh, Pam Royle, Paul Steward, Rachel Lucas, Robert Ellis
Publikováno v:
Health Technology Assessment, Vol 25, Iss 64 (2021)
Background: Malignant melanoma is the fifth most common cancer in the UK, with rates continuing to rise, resulting in considerable burden to patients and the NHS. Objectives: The objectives were to evaluate the effectiveness and cost-effectiveness of
Externí odkaz:
https://doaj.org/article/21247debab3e4d9bb4ce2c282c8aa36f
Publikováno v:
Cancer Cell International, Vol 19, Iss 1, Pp 1-15 (2019)
Abstract Background Emergence of resistance to molecular targeted therapy constitutes a limitation to clinical benefits in cancer treatment. Cross-resistance commonly happens with chemotherapeutic agents but might not with targeted agents. Methods In
Externí odkaz:
https://doaj.org/article/d52f6c520f674aa0ad3934c0311b3100
Publikováno v:
Frontiers in Oncology, Vol 6 (2016)
Prognosis and survival for malignant melanoma is highly dependent on early diagnosis and treatment. While the American Joint Committee on Cancer (AJCC) criteria provides a means of staging melanomas and guiding treatment approaches, it is unable to i
Externí odkaz:
https://doaj.org/article/8bc770ee53b34e72b6095dbbf067e2bd
Autor:
George Kelly, Tetsushi Kataura, Peter Banks, Glyn Nelson, Daniel Moscoh Ayine-Tora, Laura Dobby, Gailing Ma, Lydia Costello, Bernadette Carroll, Penny Lovat, Hanna Salmonowicz, Lino Ferreira, Stefan Przyborski, Thomas von Zglinicki, Satomi Miwa, Jóhannes Reynisson, John E. Oblong, Charles C. Bascom, Viktor Korolchuk
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Journal of Clinical Oncology. 40:e21541-e21541
e21541 Background: While surgical excision is largely curative, small subsets of patients with cSCC develop metastatic disease for which current AJCC/Brigham and Women’s Hospital staging criteria are unable to reliably identify. There is hence an u
Autor:
Bernadette, Carroll, Glyn, Nelson, Yoana, Rabanal-Ruiz, Olena, Kucheryavenko, Natasha A, Dunhill-Turner, Charlotte C, Chesterman, Qabil, Zahari, Tong, Zhang, Sarah E, Conduit, Christina A, Mitchell, Oliver D K, Maddocks, Penny, Lovat, Thomas, von Zglinicki, Viktor I, Korolchuk
Publikováno v:
The Journal of Cell Biology
It is unclear how mTORC1 signaling differs in senescent and young cells. Carroll et al. show that senescence leads to constitutive mTORC1 activation and resistance to serum and amino acid starvation. This is associated with elevated autophagy, depola
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9fc81c1b9491867943b363f25d386a4c
https://ora.ox.ac.uk/objects/uuid:66e2a656-78cf-4fcf-a25f-a3693f6b010c
https://ora.ox.ac.uk/objects/uuid:66e2a656-78cf-4fcf-a25f-a3693f6b010c